Summit Therapeutics at Barclays 26th Global Healthcare Conference
Summit Therapeutics (NASDAQ: SMMT) will present at the Barclays 26th Global Healthcare Conference in Miami Beach, FL from March 12-14, 2024. CEO Dr. Maky Zanganeh and Chairman Robert W. Duggan…
2032 Myocardial Infarction Treatment Insights: FARXIGA Forecast – ResearchAndMarkets.com
ResearchAndMarkets.com is pleased to announce the addition of the “FARXIGA Market Size, Forecast, and Emerging Insight – 2032” report to its offerings. This comprehensive report delves into the impact and…
Merck’s Involvement Confirmed for the Barclays 26th Annual Global Healthcare Conference
Merck (NYSE: MRK), also known as MSD outside the United States and Canada, has revealed that Jannie Oosthuizen, President of Human Health U.S., is set to engage in a fireside…
Expanded Collaboration for Neoantigen Cancer Vaccine Trial
Transgene (Euronext Paris: TNG), a biotechnology company specializing in virus-based immunotherapies for cancer treatment, NEC Corporation (NEC; TSE: 6701), a leader in IT, network, and AI technologies, and BostonGene Corporation…
United Therapeutics Corporation Scheduled to Participate in the Leerink Partners Global Biopharma Conference 2024
United Therapeutics Corporation (Nasdaq: UTHR), a leading public benefit corporation, has disclosed that Patrick Poisson, Executive Vice President of Technical Operations, will participate in a fireside chat session at the…
Successful Large-Scale GMP Manufacturing of MOv18 IgE Antibody for Ovarian Cancer by Epsilogen and Lonza
Epsilogen and Lonza Achieve Breakthrough in Manufacturing IgE Antibody for Ovarian Cancer Treatment Epsilogen, a leader in developing IgE antibodies for cancer therapy, and Lonza, a global partner in pharmaceutical…
PDA India Chapter Annual Meeting: Ensuring Quality & Compliance in Pharma Manufacturing and Regulatory Standards – March 11-15, Hyderabad, India
PQE Group eagerly anticipates participating in the 2024 PDA India Chapter Annual Meeting in Hyderabad from March 11-15, focusing on critical issues in the pharmaceutical and medical device sectors. The…
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
Vivani Medical, Inc. (Nasdaq: VANI), a pioneering biopharmaceutical company in the preclinical stage, has recently announced a significant move towards advancing its innovative long-term drug implants. In a registered direct…
BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
President and CEO of Bio-Techne, Kim Kelderman, commented on the results, acknowledging the team’s resilience in a challenging environment. He expressed optimism regarding the stabilization observed in China and reiterated…
Shionogi and Nagasaki University Launch Second Phase of Collaborative Effort in Combatting Malaria and Infectious Diseases
Shionogi & Co., Ltd. (Headquartered in Osaka, Japan; CEO: Isao Teshirogi, Ph.D.; referred to as “Shionogi” hereafter) has initiated the second phase of collaboration with Nagasaki University (Located in Nagasaki,…
Shionogi and Osaka University Establish a New Joint Research Lab on Post-COVID-19 Condition (Long COVID)
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced that Shionogi and Osaka University (Location: Suita, Osaka, President: Shojiro Nishio) have established…
WuXi Biologics Ireland Site Receives Three ISO Certifications
WuXi Biologics (2269.HK), a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), proudly announces the reception of three esteemed International Organization for Standardization (ISO) certifications at its Ireland facility.…